Publicaciones en las que colabora con M. Jurado (17)

2024

  1. PTCy vs CNI–based GVHD prophylaxis in HLA-matched transplants for Hodgkin lymphoma: a study of the LWP of the EBMT

    Blood Advances, Vol. 8, Núm. 15, pp. 3985-3992

  2. Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis in HLA-Matched and Haploidentical Donor Transplantation for Patients with Hodgkin Lymphoma: A Comparative Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation

    Transplantation and Cellular Therapy, Vol. 30, Núm. 2, pp. 210.e1-210.e14

2021

  1. Polymorphisms within the TNFSF4 and mapkapk2 loci influence the risk of developing invasive aspergillosis: A two-stage case control study in the context of the aspbiomics consortium

    Journal of Fungi, Vol. 7, Núm. 1, pp. 1-17

2020

  1. Host immune genetic variations influence the risk of developing acute myeloid leukaemia: results from the NuCLEAR consortium

    Blood Cancer Journal, Vol. 10, Núm. 7

  2. Polymorphisms within the ARNT2 and CX3CR1 genes are associated with the risk of developing invasive aspergillosis

    Infection and Immunity, Vol. 88, Núm. 4

  3. Risk factors and outcome of COVID-19 in patients with hematological malignancies

    Experimental Hematology and Oncology, Vol. 9, Núm. 1

2019

  1. Acute GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute myeloid leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomised study

    The Lancet Haematology, Vol. 6, Núm. 2, pp. e89-e99

2017

  1. Adipose tissue-derived mesenchymal stromal cells as part of therapy for chronic graft-versus-host disease: A phase I/II study

    Cytotherapy, Vol. 19, Núm. 8, pp. 927-936

2016

  1. Antilymphocyte globulin for prevention of chronic graft-versus-host disease

    New England Journal of Medicine, Vol. 374, Núm. 1, pp. 43-53

  2. Common genetic polymorphisms within NFκB-related genes and the risk of developing invasive aspergillosis

    Frontiers in Microbiology, Vol. 7, Núm. AUG

  3. Outcome of Second Allogeneic Hematopoietic Cell Transplantation after Relapse of Myeloid Malignancies following Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort on Behalf of the Grupo Español de Trasplante Hematopoyetico

    Biology of Blood and Marrow Transplantation, Vol. 22, Núm. 3, pp. 584-588

  4. Polymorphisms in host immunity-modulating genes and risk of invasive aspergillosis: Results from the AspBIOmics Consortium

    Infection and Immunity, Vol. 84, Núm. 3, pp. 643-657

2005

  1. Absence of clinically relevant effect of caspofungin on cyclosporin pharmacokinetics

    Swiss Medical Weekly

2004

  1. Safety of the concomitant use of caspofungin and cyclosporin A in patients with invasive fungal infections

    Bone Marrow Transplantation, Vol. 34, Núm. 1, pp. 13-20

2001

  1. Favourable effect of the combination of acute and chronic graft-versus-host disease on the outcome of allogeneic peripheral blood stem cell transplantation for advanced haematological malignancies

    British Journal of Haematology, Vol. 114, Núm. 3, pp. 544-550

1998

  1. Allogeneic transplantation of purified CD34+ cells from peripheral blood: Spanish experience of 62 cases

    Bone Marrow Transplantation

  2. Allogeneic transplantation of selected CD34+ cells from peripheral blood: Experience of 62 cases using immunoadsorption or immunomagnetic technique

    Bone Marrow Transplantation, Vol. 22, Núm. 6, pp. 519-525